M1 CRPC: PARP Inhibitors and Precision Medicine (2026)
🛍️ Products Mentioned (1)
The Evolving Landscape of Advanced Prostate Cancer Treatment: A Guidelines and Case-Based Discussion (2026): M1 CRPC: PARP Inhibitors and Precision Medicine Speaker: Kristen R. Scarpato, MD, MPH CME Available: https://cme.auanet.org/URL/AUASUO261ONL ACKNOWLEDGEMENTS: Support provided by independent educational grants from: Astellas, AstraZeneca, Blue Earth Diagnostics, Inc., Lantheus Medical Imaging, Merck & Co. Inc., Novartis Pharmaceuticals Corporation and Pfizer, Inc.
🎬 More from AUAUniversity
AUA Guidelines: Advanced Prostate Cancer
4 views
Capitol Stream: Advancing Men’s Health on Capitol Hill
7 views
AUA2026: Focus on: Metastatic Urothelial Carcinoma (mUC)
92 views
Use of Ambient Listening AI Scribes: Improved Wellness and Efficiency in the Outpatient Setting
48 views
Global Perspectives: Lessons in Innovation, Resourcefulness, and Collaboration from Brazil
29 views
AUA Guidelines: Clinically Localized Prostate Cancer
292 views